Aviscumine
Aviscumine Uses, Dosage, Side Effects, Food Interaction and all others data.
Cy 503 is under investigation in clinical trial NCT00658437 (Aviscumine for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy).
| Trade Name | Aviscumine |
| Generic | Aviscumine |
| Aviscumine Other Names | Aviscumine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Aviscumine
